Cigna Defeats Class Cert. Bid In ERISA Suit Over Drug Prices
Participants in Cigna-administered health plans on Thursday lost their bid to certify a proposed class action accusing the insurer of scheming to overcharge beneficiaries for prescription drugs, with a Connecticut federal...To view the full article, register now.
Already a subscriber? Click here to view full article